SCHEMBL16215345

SCHEMBL16215345

CCCCCCc1ccc(-c2ccc(N=C=S)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY6 Q15077 1/20 0.59
HSD17B10 Q99714 3/20 0.55
TSHR P16473 1/20 0.55
RARB P10826 7/20 0.50
ALDH1A1 P00352 3/20 0.50
MEN1 O00255 2/20 0.50
MAPT P10636 2/20 0.50
KMT2A Q03164 2/20 0.50
RARA P10276 2/20 0.50
MTOR P42345 1/20 0.50
CYP3A4 P08684 2/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
ESR1 P03372 2/20 0.47
ADRA2A P08913 2/20 0.47
ADORA3 P0DMS8 2/20 0.47
TACR2 P21452 2/20 0.47
SLC6A2 P23975 2/20 0.47
SLC6A4 P31645 2/20 0.47
SLC6A3 Q01959 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9347524 1.00 P2RY6 (0.59) P2RY6HSD17B10TSHRRARBALDH1A1
SCHEMBL1274079 0.98 P2RY6 (0.62) P2RY6HSD17B10TSHRRARBALDH1A1
SCHEMBL9347327 0.98 P2RY6 (0.61) P2RY6HSD17B10TSHRRARBALDH1A1
SCHEMBL6157114 0.95 P2RY6 (0.66) P2RY6HSD17B10TSHRALDH1A1CYP3A4
SCHEMBL11210604 0.95 P2RY6 (0.66) P2RY6HSD17B10TSHRALDH1A1CYP3A4
SCHEMBL18245390 0.95 P2RY6 (0.66) P2RY6HSD17B10TSHRALDH1A1CYP3A4
SCHEMBL29306033 0.93 P2RY6 (0.63) P2RY6HSD17B10TSHRRARBALDH1A1
SCHEMBL11856911 0.93 P2RY6 (0.68) P2RY6HSD17B10TSHRALDH1A1CYP3A4
SCHEMBL29305831 0.91 HSD17B10 (0.54) P2RY6HSD17B10TSHRRARBALDH1A1
SCHEMBL1457664 0.88 P2RY6 (0.70) P2RY6HSD17B10RARBALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228878-A1 COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME DIC CORPORATION (JP) 2024-07-11 US disclosed
US-20240228878-A1 COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME DIC CORPORATION (JP) 2024-07-11 US disclosed
US-20240190866-A1 POLYHYDROXYLATED INDOLIZIDINE AND PYRROLIZIDINE DERIVATIVES AND USES THEREOF ACADEMIA SINICA (TW) 2024-06-13 US disclosed
EP-4308108-A1 POLYHYDROXYLATED INDOLIZIDINE AND PYRROLIZIDINE DERIVATIVES AND USES THEREOF Academia Sinica (TW) 2024-01-24 EP disclosed
WO-2022197564-A1 POLYHYDROXYLATED INDOLIZIDINE AND PYRROLIZIDINE DERIVATIVES AND USES THEREOF ACADEMIA SINICA (TW) 2022-09-22 WO disclosed
US-10934486-B2 Liquid crystal composition, liquid crystal mixture, reverse-mode polymer dispersed liquid crystal element, and associated selectively dimmable device NITTO DENKO CORPORATION (JP) 2021-03-02 US disclosed
US-20200347302-A1 LIQUID CRYSTAL COMPOSITION CONTAINING A FIVE-MEMBERED HETEROCYCLIC RING, REVERSE-MODE POLYMER DISPERSED LIQUID CRYSTAL ELEMENT, AND ASSOCIATED SELECTIVELY DIMMABLE DEVICE NITTO DENKO CORPORATION (JP) 2020-11-05 US disclosed
US-20190233728-A1 LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL MIXTURE, REVERSE-MODE POLYMER DISPERSED LIQUID CRYSTAL ELEMENT, AND ASSOCIATED SELECTIVELY DIMMABLE DEVICE NITTO DENKO CORPORATION (JP) 2019-08-01 US disclosed
WO-2018152257-A1 LIQUID CRYSTAL COMPOSITION CONTAINING A FIVE-MEMBERED HETEROCYCLIC RING, REVERSE-MODE POLYMER DISPERSED LIQUID CRYSTAL ELEMENT, AND ASSOCIATED SELECTIVELY DIMMABLE DEVICE NITTO DENKO CORPORATION (JP) 2018-08-23 WO disclosed
US-9175220-B2 High scattering smectic liquid crystal material and display device using the same HALATION PHOTONICS CORPORATION (CN) 2015-11-03 US disclosed
EP-2799516-A1 LIQUID CRYSTAL MATERIAL OF SMECTIC PHASE IN HIGH SCATTERING STATE AND DISPLAY DEVICE THEREOF Halation Photonics Corporation (CN) 2014-11-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240190866-A1 POLYHYDROXYLATED INDOLIZIDINE AND PYRROLIZIDINE DERIVATIVES AND USES THEREOF PHKB, BET1, IDO1 P2RY6 2857/4885HSD17B10 1704/4885TSHR 2971/4885
US-20240228878-A1 COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME TTI2, CCT4, CCT2 P2RY6 3057/4885HSD17B10 4365/4885TSHR 196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.